| Literature DB >> 25017667 |
Feng-Chih Kuo, Chi-Hsiang Hsu, Wun-Schen Chen, Jun-Wen Wang.
Abstract
BACKGROUND: The patients aged ≥ 80 years have been considered to have a higher risk of mortality, postoperative complications, and longer hospital stay following total knee arthroplasty (TKA) than younger patients. The purposes of this retrospective study were to review the results of TKA in patients aged ≥ 80 years after a preoperative consultation.Entities:
Mesh:
Year: 2014 PMID: 25017667 PMCID: PMC4131159 DOI: 10.1186/s13018-014-0061-z
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Patients' characteristics
| Mean age (year) | 82 (2.8; 80–93) | 72 (2.2; 65 ~ 74) | <0.001 |
| Female, | 54 (72) | 62 (82) | 0.144 |
| Mean BMI (kg/m2) | 26.2 (3.0; 19.5–35.5) | 28.2 (3.7; 21.5–38.9) | 0.078 |
| OA/RA/PTA, | 73/2/0 | 72/2/1 | 0.528 |
| ASA risk, | | | 0.1 |
| I | 0 | 2 (2.7) | |
| II | 42 (56) | 50 (66.6) | |
| III | 33 (44) | 23 (30.7) | |
| Anesthesia, | | | 0.684 |
| General | 73 (97.3) | 72 (96) | |
| Spinal | 2 (2.7) | 3 (4) |
Numbers in parenthesis are standard deviation and ranges. OA osteoarthritis, RA rheumatoid arthritis, PTA post-traumatic arthritis, ASA American Society of Anesthesiologist.
Preoperative data
| KSS, points | 38 (7.1; 18–56) | 40 (4.8; 30–52) | 0.245 |
| KSFS, points | 42 (8.1; 20–60) | 44 (5.0; 30–56) | 0.645 |
| WOMAC, points | 76.2 (9.1; 54–88) | 75.4 (7.8; 53–83) | 0.557 |
| TFM | 11.9° varus (20.3° valgus to 29° varus) | 9.4° varus (8° valgus to 29.8° varus) | 0.936 |
| ROM | 107° (20.9°; 35°–135°) | 113° (12.8°; 70°–135°) | 0.057 |
SD standard deviation, KSS Knee Society Score, KSFS Knee Society Function Score, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, TFM tibiofemoral mechanical axis, ROM range of knee motion.
Prevalence of comorbidities
| DM | 19 | 20 | 0.973 |
| Cardiac | | | |
| Hypertension | 52 | 53 | 0.82 |
| CAD | 7 | 5 | 0.497 |
| CHF | 2 | 1 | 0.614 |
| Arrhythmia | 6 | 3 | 0.32 |
| Liver cirrhosis | 0 | 2 | 0.497 |
| Renal insufficiency | 4 | 4 | 0.951 |
| Gout | 2 | 3 | 0.684 |
| COPD | 5 | 7 | 0.598 |
| Adrenocortical insufficiency | 7 | 4 | 0.311 |
| Peptic ulcer | 13 | 11 | 0.575 |
| Coagulopathy | 0 | 2 | 0.497 |
| Anemiaa | 17 | 14 | 0.459 |
| Hemoglobin (g/dL), mean (SD; range) | 12.7 (1.7; 8.8 ~ 16.7) | 13.2 (1.4; 9.8 ~ 16.9) | 0.115 |
| Hematocrit, mean (SD; range) | 39.1 (4.0; 30.5 ~ 48.1) | 40.2 (3.9; 30.3 ~ 49.9) | 0.082 |
DM diabetes mellitus, CAD coronary artery disease, CHF congestive heart failure, CVA cerebral vascular accident, COPD chronic obstructive pulmonary disease, SD standard deviation. aHb < 12 g/dL.
Intraoperative and postoperative data
| Tube drainage, mL | 493 (173; 201–1,015) | 460 (179; 188–920) | 0.429 |
| Wound length, cm | 10.3 (1.1; 7.8–13) | 9.9 (0.9; 8–13) | 0.107 |
| Length of stay, day | 6.1 (1.3; 5–11) | 5.7 (1.2; 4–12) | 0.061 |
| KSS, points | 86 (4.1; 72–92) | 88 (4.1; 76–94) | 0.77 |
| KSFS, points | 87 (3.8; 70–88) | 89 (4.0; 78–92) | 0.936 |
| WOMAC, points | 15.0 (7.9; 2–39) | 14.6 (6.4; 1–35) | 0.681 |
| TFM | 0.22° valgus (2.9° valgus to 2.4° varus) | 0.05° varus (2.4° valgus to 2.6° varus) | 0.109 |
| ROM | 118° (8.7°; 95°–145°) | 120° (11.4°; 90°–140°) | 0.811 |
KSS Knee Society Score, KSFS Knee Society Function Score, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, TFM tibiofemoral mechanical axis, ROM range of knee motion.
Number of complications within 90 days after total knee arthroplasty
| Confusion, | 5 (6.7%) | 0 (0%) | 0.026 |
| Pneumonia, | 2 (2.7%) | 1 (1.3%) | 0.614 |
| MI, | 0 (0%) | 1 (1.3%) | 0.243 |
| DVT with positive venogram, | 1 (1.3%) | 2 (2.7%) | 0.584 |
| ICU care, | 1 (1.3%) | 1 (1.3%) | 0.976 |
| Postop CHF, | 1 (1.3%) | 0 (0%) | 0.49 |
| PE, | 0 (0%) | 1 (1.3%) | 0.326 |
| UGI bleeding, | 3 (4%) | 0 (0%) | 0.115 |
| Anemia, | 17 (22.7%) | 18 (24%) | 0.959 |
| Atelectasis, | 3 (4%) | 1 (1.3%) | 0.359 |
| Superficial wound infection, | 4 (5.3%) | 1 (1.3%) | 0.203 |
| Number of patients receiving transfusion, | 22 (29.3%) | 8 (10.7%) | 0.003 |
MI myocardial infarction, DVT deep vein thrombosis, CHF congestive heart failure, PE pulmonary embolism, UGI upper gastrointestinal, ICU intensive care unit. *Bonferroni-adjusted significance level of 0.00416.